Evidence map›Paper›PMID 18266981›Full record

ArticleJournal of cellular and molecular medicine2008

Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium.

S Varma Penumathsa, M Thirunavukkarasu, L Zhan, G Maulik, V P Menon, D Bagchi, N Maulik

Erratum issued Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT02114892 (Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion), which is not on this map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02114892 phase2completednot on this mapstarted 2012, after this paper: background citation

Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion

TypeinterventionalSponsorUniversity of GuadalajaraRan2012 to 2013Enrolled24ConditionsMetabolic Syndrome XArmsResveratrol, Placebo
3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 173 citations in OpenAlex.

  1. Review
  2. Stilbenes from Vine Extracts: Therapeutic Potential and Mechanisms.International journal of molecular sciences · 2025
    Review
  3. Role of membrane microdomains in cardiac protection: strategies for diabetic cardiomyopathy.American journal of physiology. Heart and circulatory physiology · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

S Varma PenumathsaMolecular Cardiology and Angiogenesis Laboratory, Department of Surgery, University of Connecticut Health Center, Farmington, CT 06030-1110, USA.
M Thirunavukkarasu
L Zhan
G Maulik
V P Menon
D Bagchi
N Maulik
UConn Health · USAnnamalai University · INHarvard University · US

Funding

Ventricular Remodeling in the Adapted HeartR01HL069910 · NHLBI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI MAULIK, NILANJANA · 2003 to 2012
$3.4M
PRECONDITIONING IN OPEN HEART SURGERYR01HL056803 · NHLBI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI MAULIK, NILANJANA · 2000 to 2011
$3.1M
Mechanism of Myocardial Angiogenesis in Transgenic/Knockout AnimalsR01HL085804 · NHLBI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI MAULIK, NILANJANA · 2006 to 2010
$1.8M
PRECONDITIONING IN OPEN HEART SURGERYR29HL056803 · NHLBI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI MAULIK, NILANJANA · 1998 to 1999
–
NHLBI NIH HHS HL 56803NHLBI NIH HHS HL 69910NHLBI NIH HHS HL 85804NHLBI NIH HHS R01 HL056803NHLBI NIH HHS R01 HL069910NHLBI NIH HHS R01 HL085804NHLBI NIH HHS R29 HL056803
6 · The paper itself

Abstract

Homeostasis of blood glucose by insulin involves stimulation of glucose uptake by translocation of glucose transporter Glut-4 from intracellular pool to the caveolar membrane system. In this study we examined resveratrol (RSV)-mediated Glut-4 translocation in the streptozotocin (STZ)-induced diabetic myocardium. The rats were randomized into three groups: Control (Con), Diabetes Mellitus (DM) (STZ 65 mg/kg b.w., i.p.) & DM+RSV (2.5 mg/kg b.wt. for 2 weeks orally) (RSV). Isolated rat hearts were used as per the experimental model. RSV induced glucose uptake was observed in vitro with H9c2 cardiac myoblast cells. Decreased blood glucose level was observed after 30 days (375 mg/dl) in RSV-treated rats when compared to DM (587 mg/dl). Treatment with RSV demonstrated increased Adenosine Mono Phosphate Kinase (AMPK) phosphorylation compared to DM. Lipid raft fractions demonstrated decreased expression of Glut-4, Cav-3 (0.4, 0.6-fold) in DM which was increased to 0.75- and 1.1-fold on RSV treatment as compared to control. Increased Cav-1 expression (1.4-fold) in DM was reduced to 0.7-fold on RSV treatment. Increased phosphorylation of endothelial Nitric Oxide Synthase (eNOS) & Akt was also observed in RSV compared to DM (P<0.05). Confocal microscopy and coimmunoprecipitation studies demonstrated decreased association of Glut-4/Cav-3 and increased association of Cav-1/eNOS in DM as compared to control and converse results were obtained on RSV treatment. Our results suggests that the effect of RSV is non-insulin dependent and triggers some of the similar intracellular insulin signalling components in myocardium such as eNOS, Akt through AMPK pathway and also by regulating the caveolin-1 and caveolin-3 status that might play an essential role in Glut-4 translocation and glucose uptake in STZ- induced type-1 diabetic myocardium.

Indexed as

AMP-Activated Protein KinasesAnimalsBiological Transport, ActiveBlood GlucoseCaveolaeCaveolin 1Caveolin 3DeoxyglucoseDiabetes Mellitus, ExperimentalGlucose Transporter Type 4ImmunohistochemistryIn Vitro TechniquesMaleMyocardiumMyocytes, CardiacNitric Oxide Synthase Type IIIAMP-Activated Protein KinasesBlood GlucoseCav1 protein, ratCav3 protein, ratCaveolin 1Caveolin 3DeoxyglucoseGlucose Transporter Type 4Nitric Oxide Synthase Type IIINos3 protein, ratProto-Oncogene Proteins c-aktResveratrolSlc2a4 protein, ratStilbenes

Identifiers

PMID18266981
PMCPMC4514113
OpenAlexW2136074431

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.